News & Updates

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

07 Aug 2024

New drug applications approved by US FDA as of 16-31 May 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

07 Aug 2024

From Rashes to Changes: 6 Skin Signs That Could Indicate Heart Problems

07 Aug 2024

Your skin often reflects your overall health, including the condition of your heart. While it’s not always straightforward, certain skin changes and rashes can be early indicators of heart problems. Understanding these signs can help you catch potential issues before they escalate.

From Rashes to Changes: 6 Skin Signs That Could Indicate Heart Problems

07 Aug 2024

Updated melanoma guidelines stress consensus, clear safety margins

07 Aug 2024 by

German experts came together to update guidelines on melanoma management and create consensus out of fragmented standards of care by experts across multiple fields.

Updated melanoma guidelines stress consensus, clear safety margins

07 Aug 2024

FLASH: Light-activated hypericin ointment gets high marks in early-stage mycosis fungoides

06 Aug 2024 by

Photodynamic therapy using topically applied hypericin 0.25% is effective against early-stage patch and plaque lesions in patients with mycosis fungoides−cutaneous T-cell lymphoma, while having a favourable safety profile, as shown in the phase III FLASH trial.

FLASH: Light-activated hypericin ointment gets high marks in early-stage mycosis fungoides

06 Aug 2024

Clues to help manage pediatric skin infections

30 Jul 2024 by

Diagnosing fungal and viral skin infections may pose a challenge to many clinicians. But according to Dr. Roberta Romero, a fellow of the Philippine Dermatological Society and officer-in-charge of the Tropical Diseases Foundation at the Makati Medical Center, there are distinct clues in the history and physical examination of a patient that can help the clinician diagnose and treat pediatric skin conditions caused by dermatophytes, yeasts and viruses.

Clues to help manage pediatric skin infections

30 Jul 2024

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

20 Jul 2024

Use of cycline antibiotics (CAs) is associated with an elevated risk of pseudotumour cerebri syndrome (PTCS) or papilledema, suggests a recent study. However, no statistically significant link between CA use and PTCS development is seen when accounting for confounding factors.

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

20 Jul 2024

Pembrolizumab effective against mucosal melanoma and bladder cancer

12 Jun 2024 by

Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer.

Pembrolizumab effective against mucosal melanoma and bladder cancer

12 Jun 2024

Melanoma mortality rates to drop by 2050

12 Jun 2024 by

Mortality rates of melanoma are predicted to fall by 2050, but the number of individuals dying from the disease will increase due to population growth and ageing.

Melanoma mortality rates to drop by 2050

12 Jun 2024

BP-lowering meds spell small increase in eczematous dermatitis rates for older adults

29 May 2024 by

The use of blood pressure (BP)-lowering medications may slightly raise the incidence of eczematous dermatitis among older adults, with the magnitude of effect being largest for calcium channel blockers and diuretic drugs and smallest for angiotensin-converting enzyme (ACE) inhibitors and β-blockers, according to a study.

BP-lowering meds spell small increase in eczematous dermatitis rates for older adults

29 May 2024

Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis

28 May 2024 by

Treatment with dupilumab substantially improves symptoms, quality of life, and other outcomes in patients with atopic hand and foot dermatitis (H/F AD), with an acceptable safety profile, results of a study have shown.

Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis

28 May 2024

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

From Rashes to Changes: 6 Skin Signs That Could Indicate Heart Problems

From Rashes to Changes: 6 Skin Signs That Could Indicate Heart Problems

Updated melanoma guidelines stress consensus, clear safety margins

Updated melanoma guidelines stress consensus, clear safety margins

FLASH: Light-activated hypericin ointment gets high marks in early-stage mycosis fungoides

FLASH: Light-activated hypericin ointment gets high marks in early-stage mycosis fungoides

Clues to help manage pediatric skin infections

Clues to help manage pediatric skin infections

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

Cycline antibiotics may increase risk of pseudotumour cerebri syndrome

Pembrolizumab effective against mucosal melanoma and bladder cancer

Pembrolizumab effective against mucosal melanoma and bladder cancer

Melanoma mortality rates to drop by 2050

Melanoma mortality rates to drop by 2050

BP-lowering meds spell small increase in eczematous dermatitis rates for older adults

BP-lowering meds spell small increase in eczematous dermatitis rates for older adults

Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis

Dupilumab lessens symptoms, betters life quality in atopic hand and foot dermatitis